Perrigo Company plc Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Perrigo Company plc stock issued during period, value, stock options exercised for the quarter ending 2019-09-28 was $400.00K, a 20.00% decline year-over-year.
- Perrigo Company plc stock issued during period, value, stock options exercised for the quarter ending 2019-06-29 was $300.00K, a 200.00% increase year-over-year.
- Perrigo Company plc stock issued during period, value, stock options exercised for the quarter ending 2018-09-29 was $500.00K.
- Perrigo Company plc stock issued during period, value, stock options exercised for the quarter ending 2018-06-30 was $100.00K.
- Perrigo Company plc stock issued during period, value, stock options exercised for fiscal 2019 was $900.00K, a 30.77% decline from fiscal 2018.
- Perrigo Company plc stock issued during period, value, stock options exercised for fiscal 2018 was $1.30M, a 85.71% increase from fiscal 2017.
- Perrigo Company plc stock issued during period, value, stock options exercised for fiscal 2017 was $700.00K, a 91.57% decline from fiscal 2016.
- Perrigo Company plc stock issued during period, value, stock options exercised for fiscal 2016 was $8.30M.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2019-12-31 | $900.00K 10-K · filed 2022-03-01 | |
| 2019-09-28 | $400.00K 10-Q · filed 2020-11-05 | |
| 2019-06-29 | $300.00K 10-Q · filed 2020-11-05 | |
| 2018-12-31 | $1.30M 10-K · filed 2021-03-01 | |
| 2018-09-29 | $500.00K 10-Q · filed 2019-11-06 | |
| 2018-06-30 | $100.00K 10-Q · filed 2019-11-06 | |
| 2018-03-31 | $200.00K 10-Q · filed 2019-11-06 | |
| 2017-12-31 | $700.00K 10-K · filed 2020-02-27 | |
| 2016-12-31 | $8.30M 10-K · filed 2019-02-27 | |
| 2015-06-27 | $8.50M 10-K · filed 2018-03-01 | |
| 2014-06-28 | $9.80M 10-K · filed 2017-05-22 | |
| 2013-06-29 | $10.70M 10-KT · filed 2016-02-25 | |
| 2012-06-30 | $11.60M 10-K · filed 2014-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |